Abstract. Women with polycystic ovary syndrome (PCOS) are characterized by excess androgen secretion and anovulatory infertility as a cause of follicular maturation arrest, and they are also associated with insulin resistance and obesity. Recently, it was suggested that one of the etiologies for PCOS is an abnormality of steroid hormones, and excessive secretion of androgen. The endoplasmic reticular cytochrome P450, 17α-hydroxylase (CYP17A), plays a key role in the mechanism of steroid hormones such as adrenal and gonadal steroid biosynthesis. Therefore, we studied the association between single nucleotide polymorphisms (SNPs) of the A1 allelic variant of the CYP17 gene and PCOS in a Korean population. The study recruited 134 Korean women with PCOS and 100 healthy women as controls. Using the HapAnalyzer, the genotype of the CYP17A1 polymorphism in PCOS and control patients were analyzed. We considered a p-value lower than 0.05 to be statistically significant. After genotypic analysis, we found seven SNPs of the CYP17A1 gene in a large population of subjects. The frequency of seven SNPs had no significant association with PCOS. However, one haplotype (ht3) had a p-value of p=0.001, suggesting that it may be associated with the pathogenesis of PCOS in a Korean population.
Introduction
Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders occurring in 4-12% of women of reproductive age (1, 2) . According to a previous study, 4.9% of female college students in Korea manifested PCOS (3) . Women with PCOS represent various phenotypes such as polycystic ovary morphology, obesity, hyperandrogenism, and anovulation infertility (6) (7) (8) . Many metabolic abnormalities of PCOS lead to metabolic syndromes such as type 2 diabetes mellitus, dyslipidemia, and hypertension in postmenopausal women with PCOS (9, 10) .
Insulin production, excessive secretion of androgen, ovarian steroidogenic response to luteinizing hormone (LH), and FSH levels have been suggested to affect cyst formation in ovarian follicles (11) . Furthermore, a recent study showed that insulin and insulin receptor (INSR) genes play a key role as genetic factors for the pathogenesis of PCOS (11, 12) . Previous reports showed that the Pro12Ala variant of PPARγ and the single nucleotide polymorphisms (SNP) of the VEGF gene are also important components in the pathogenesis of PCOS (13, 14) .
Since women with PCOS are characterized by excess androgen secretion and anovulatory infertility as a cause of follicular maturation arrest, patients with PCOS are associated with insulin resistance and obesity (15) . Several mechanisms involved in steroid hormone synthesis have been reported in the etiology of PCOS (16, 17) . Steroid hormone synthesis pathway is associated with the regulation of androgens, insulin signaling and obesity (17) . The etiology of PCOS is involved in metabolic and/or regulatory pathway of steroid hormones, including LH and testosterone (18) . Recently, it was suggested that one of the etiologies for PCOS is an abnormality of steroid hormones, and excessive androgen secretion (17, 18) .
A number of SNP studies suggested that the dysregulatory steroidogenic enzyme P45c17α may be critically related to the etiology of hyperandrogenism in PCOS. Steroid hormones are produced from cholesterol via CYP enzymes such as CYP11A, CYP11B1, CYP11B2, CYP17, CYP19, and CYP21. One of the CYP enzymes causing hyperandrogenism is encoded by 17α-hydroxylase-17,20-lyase (CYP17) located on chromosome 10q24-q25. The endoplasmic reticular cytochrome P450, 17α-hydroxylase, plays a key role in the mechanism of steroid hormones such as adrenal and gonadal steroid biosynthesis (19) . CYP17 is a key enzyme in the steroidogenic pathway and is known to produce progestins, mineralocorticoids, glucocorticoids, androgens, and estrogens. SNPs of CYP17 are associated with several diseases including PCOS, breast cancer, Cushing's syndrome, and prostate cancer in different ethnic groups (20) . Two alleles of CYP17 changed from thymine (T) to cytosine (C) at -34 bp are denoted as A1 allele and A2 allele, respectively (19) . The CYP17A1 gene encodes a member of the cytochrome P450 superfamily of enzymes.
Recently, numerous SNPs have been investigated by association studies in PCOS patients. One of the SNPs involved in steroidogenic alteration leads to an adrenal hyperandrogenism in PCOS patients (22, 23) . The CYP11a gene is a candidate gene for abnormal steroidogenesis and the P450 side chain cleavage enzyme of cholesterol. A microsatellite polymorphism (tttta) n of CYP11a located at 528 bp upstream from the initiation site of the translation, which encodes cytochrome P450scc, is associated with both PCOS and testosterone level (24) . It has been reported that the frequency of heterozygosity for CYP21 mutation in children with premature pubarche and in adolescent girls with hyperandrogenism is increased (25) .
In the present study, we investigated the relationship between the pathogenesis of PCOS and several polymorphisms of the CYP17A1 gene. The aim of this study was to identify whether the frequency of 7 SNPs including -600C>A, -34C>T, +723G>A, +2612T>C, +4259C>T, +4444C>G, and +4994C>T in CYP17A1 is associated with PCOS in a Korean population.
Materials and methods

Subjects.
For the purposes of this study we recruited 134 women diagnosed for PCOS based on the revised diagnostic criteria recommended in 2003 by the American Society for Reproductive Medicine/European Society for Human Reproduction and Embryology (ASRM/ESHRE) Rotterdam consensus (4, 5) , and another 100 women with a similar body mass index (BMI). Blood samples were collected after 2-3 days of menstruation from both PCOS and the control groups in a Korean population for both biochemical assay and DNA sequencing analysis. All subjects were recruited from the Fertility Center at CHA General Hospital located in Seoul, Korea. Clinical and biochemical characteristics of women with PCOS and the control groups are shown in Table I . To determine their state of health state, we confirmed prior medical history, and carried out physical and pelvic examinations, and complete blood chemistry. Blood samples for molecular genetic analyses were collected in tubes containing EDTA as an anticoagulant and store at 4˚C until use. All controls and patients in this study were Korean women. This SNP study using human blood samples was approved by the Institutional Review Board (IRB).
Clinical and biochemical determination. For the diagnostic criteria of women with PCOS, hyperandrogenism was defined as testosterone (T) >0.6 ng/ml and/or serum DHEAS ≥300 μg/dl (21, 22) and a reduction in the frequency of menstrual cycle between 40 days and 6 months. Clinical and biochemical characteristics of PCOS and control groups are given in Table I . In addition, other parameters were used such as plasma FSH, LH, TSH, DHEA-S, prolactin, and testosterone.
Sequencing analysis of human CYP17A1. All exons of CYP17A1 were sequenced to identify SNPs in 24 DNA samples from healthy Korean women using the ABI PRISM 3730 DNA Analyzer (Applied Biosystems, Foster City, CA, USA). Eleven primer sets for amplification and sequencing analysis were designed based on GeneBank (accession no.: NM_000102 and AC006106). Sequence variants were verified by chromatograms.
Genotyping with sequencing analysis. Amplifying primers and probes for genotyping of the polymorphic site were designed by TaqMan analysis. PCR primers and the MGB (minor groove binder) TaqMan probes were designed with Primer Express (Applied Biosystems). One allelic probe was labelled with FAM dye and the other with fluorescent VIC dye. PCRs were performed using TaqMan Universal Master mix without uracil-DNA glycosylase (UNG) (Applied Biosystems) with PCR primer concentration of 900 nM and TaqMan MGB-probe concentration of 200 nM. A 384-well format in a total reaction volume of 5 μl using 20 ng of genomic DNA was used for reaction. The plate was placed on a thermal cycler (PE9700, Applied Biosystems), heated at 50˚C for 2 min and 95˚C for 10 min followed by 40 cycles of 95˚C for 15 sec and 60˚C for 1 min. The fluorescent intensity in each well of the plate was then read by a Prism 7900HT instrument (Applied Biosystems). Using automated software (SDS 2.1), fluorescent files for each well of the plate were analyzed.
Statistical and haplotype analyses. Using the HapAnalyzer (NGRI, Seoul, Korea; www.hap.ngri.re.kr), the genotypes of CYP17A1 polymorphisms in PCOS and control patients were analyzed. We considered p<0.05 statistically significant. To determine whether the haplotypes in the CYP17A1 had association with PCOS, we analyzed those with SNPs using the HapAnalyzer. Several haplotypes and their frequencies were identified using the PL-EM program (Harvard, Boston, MA, USA; www.people.fas.harvard.edu/~junliu/plem/click. html). As a result, we obtained 5 haplotypes which had frequencies >0.05, and then performed an association test.
Results
To determine the frequency of the SNP genotypes in the CYP17A1 gene, we used TaqMan sequencing analysis for large scale genotyping, based on linkage disequilibrium (LD), location, allele frequency and haplotype-tagging status. In addition, the frequency of genotype for each SNP from PCOS patients (n=134) and controls (n=100) for this study was analysed using the TaqMan analysis program. The analyses revealed 7 SNPs in the CYP17A1 gene, -600C>A, -34C>T, +723G>A, +2612T>C, +4259C>T, +4444C>G and +4994C>T in PCOS and control subjects (Fig. 1) . However, a few samples were not taken into account because of sequencing errors.
For the diagnostic criteria of PCOS patients, we followed the guidelines defined by the ASRM/ESHRE Rotterdam consensus in 2003 (4, 5) . The clinical and biochemical information of PCOS patients and normal control groups are shown in Table I and Fig. 2 . Specific characteristics of PCOS include polycystic ovary, oligoamenorrhea, amenorrhea, hyperandrogenism and high levels of LH, DHEA-S and testosterone. Our study revealed that LH and testosterone levels in the PCOS group are two times higher than those of the control group. In addition, DHEA-S levels of the PCOS group were slightly higher than those of the control group. Although 5% of subjects were obese and/or had an irregular menstrual cycle and 2% of subjects had polycystic ovary in a control group, 93% of subjects of the same group showed no PCOS symptoms. Table I . Clinical and biochemical characteristics of patients for PCOS and control subjects. Table II . Frequencies of genotypes of the analyzed SNPs.
-----------------------------------------------------------------------------------------------------Characteristics PCOS patient (n=134) Normal control (n=100) -----------------------------------------------------------------------------------------------------
80) -----------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------Loci
Genotype PCOS cases Control Co-dominant Dominant Recessive n (%) n (%) Table II shows the frequency of genotyping in the CYP17A1 gene using TaqMan analysis. However, 7 SNPs, -600C>A, -34C>T, +723G>A, +2612T>C, +4259C>T, +4444C>G and +4994C>T in the CYP17A1 gene showed no association between PCOS patient and normal control groups (Table II) . In a previous report, the substitution of C¡T at -34 bp in the CYP17 gene was higher in a Korean population compared with a Greek population. However, it has been shown that the higher frequency of A2A2 genotype has no significant role in hyperandrogenism in women with PCOS (13) . Interestingly, our data show a slightly higher frequency of the A2A2 genotype in PCOS patients (n= 40, 30.08%) compared with that of controls (n=25, 25.25%).
---------------------------------------------------------OR (95% CI) P OR (95% CI) P OR (95% CI) P -----------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------
We also investigated the association between haplotypes consisting of seven SNPs in CYP17A1 of PCOS patients (Table III) . Among haplotypes in CYP17A1, we found five which had a frequency >0.05. We analyzed the association between these haplotypes and PCOS using the HapAnalyzer. We found that one of the haplotypes (ht3) was associated with PCOS in a Korean population. Haplotype ht3 (p=0.001) may have a significant association with the pathogenesis of PCOS in a Korean population.
Discussion
A number of candidate genes for PCOS have been involved in abnormal expression of steroidogenesis. PCOS is characterized by excess androgen secretion and aberrant folliculogenesis causing anovulatory infertility arrest (6) (7) (8) . One of the candidate genes, CYP17A1, showed elevated expression in PCOS theca cells (15) . It has been reported that the position at -34C>T in CYP17A1 was associated with reduced risk of endometrial cancer (26) . Moreover, -34C>T in CYP17A1 may influence development and progression in prostate cancer (27) . Based on previous reports, we investigated whether -34C>T in the CYP17A1 gene influences the pathogenesis of PCOS. In our study, -34C>T in CYP17A1 was not associated with PCOS (Table II ).
An RFLP study has shown that the substitution of C¡T at -34 bp in the CYP17 gene is highly associated with PCOS patients in a Korean population compared with a Greek population (19) . However, it is indicated that the high frequency of A2A2 genotype has a significant role in hyperandrogenism in women with PCOS (13) . In the present study, we confirmed that the frequency of A2A2 genotype for C¡T at -34 bp in the CYP17A1 gene is high. Therefore, we suggest that the A2A2 genotype of the C¡T variant at -34 bp in the CYP17A1 gene is highly expressed in PCOS patients compared with control subjects. Moreover, an association study using TaqMan sequencing analysis for 6 novel SNPs, -600C>A, +723G>A, +2612T>C, +4259C>T, +4444C>G and +4994C>T in the CYP17A1 gene revealed that there was no significant association (Table II) .
In addition to association tests for 7 candidate SNPs in the CYP17A1 gene, we performed haplotype analysis (Table III) . The results indicated that the haplotype ht3 (p=0.001) is associated with PCOS in this Korean population. However, haplotypes ht1, ht2, ht4 and ht5 are not associated with PCOS. Therefore, ht3 may be involved in the pathogenesis of PCOS in a Korean population.
It has been previously suggested that PCOS is associated with obesity, insulin resistance and testosterone levels (15) . The obesity, LH, and testosterone levels in PCOS groups were two times higher than in control groups when the PCOS patient group was compared with a control group. Moreover, DHEA-S levels showed a slightly higher expression in PCOS subjects. Since the pathogenesis of PCOS is caused by obesity, diabetes and steroidogenesis, various standards are required for sampling methods. Therefore, analyses of further association studies with various aspects of sampling methods are required as PCOS disorder is caused by multiple factors. Moreover, further studies on candidate genes involved in the regulation of hyperandrogenism and/or steroidogenesis in various ethnic populations are required to identify the relation of single nucleotide polymorphisms to the etiology of polycystic ovary syndrome. gene.
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